The risk that a concentration of sales channels and end customers among specific counterparties, such as medical wholesalers, medical manufacturers, testing laboratories and overseas customers, could expose the business to the deterioration of counterparties’ financial condition or fluctuations in orders. Diversifying sales channels and destinations and developing a balanced sales strategy are key challenges.